InsidersTradesSigma
메타케어 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 메타케어 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 메타케어 has recorded 63 insider filings. Market capitalisation: €22.5bn. The latest transaction was disclosed on 29 June 2026 (Other). Among the most active insiders: 초록뱀미디어. Every trade is accessible without an account.
63
Insider Decl.
0
Thresholds
·
4 ops.
Buy Volume
·
5 ops.
Sell Volume
3Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 21,515 of 26,212 companies
29.2
score / 100
Value31
Quality28
FCF yld-23%
Earn yld2.3%
EV/EBITDA14.6x
ROE0.4%
Gross mgn30%
Net mgn1.5%
Debt/EBITDA10.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 29 June 2026
Declarations63 total
3,589,876 sharesKRXDART:20260304001518
ShareKRXDART:20240702000340
359,437 sharesKRXDART:20240702000392
ShareKRXDART:20231027000411
ShareKRXDART:20230829000603
ShareKRXDART:20230828000402
25 of 63 declarations
About 메타케어
MetaCare is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare.